A framework for extremely multiplexed dextramer mapping and prediction of T cell receptor sequences to antigen specificity
T cell receptor (TCR) antigen-specific recognition is important for the adaptive immune system. Nevertheless, constructing a TCR-antigen interplay map has been difficult because of the staggering range of TCRs and antigens. Accordingly, extremely multiplexed dextramer-TCR binding assays have been just lately developed, however the utility of the following giant datasets is restricted by the shortage of sturdy computational strategies for normalization and interpretation.
Right here, we current a computational framework comprising a novel technique, ICON (Integrative COntext-specific Normalization), for figuring out dependable TCR-pMHC (peptide-major histocompatibility complicated) interactions and a neural network-based classifier TCRAI that outperforms different state-of-the-art strategies for TCR-antigen specificity prediction. We additional demonstrated that by combining ICON and TCRAI, we’re capable of uncover novel subgroups of TCRs that bind to a given pMHC through totally different mechanisms. Our framework facilitates the identification and understanding of TCR-antigen-specific interactions for fundamental immunological analysis and medical immune monitoring.
Quantifying persistence within the T-cell signaling community utilizing an optically controllable antigen receptor
T cells discriminate between wholesome and contaminated cells with outstanding sensitivity when mounting an immune response, which is hypothesized to rely on T cells combining stimuli from a number of antigen-presenting cell interactions right into a stronger response. To quantify the capability for T cells to perform this, we now have developed an antigen receptor that’s optically tunable inside cell conjugates, offering management over the length, and depth of intracellular T-cell signaling.
We observe restricted persistence inside the T-cell intracellular community on disruption of receptor enter, with indicators dissipating solely in ~15 min, and straight present sustained proximal receptor signaling is required to keep up gene transcription. T cells thus primarily accumulate the outputs of gene expression slightly than combine discrete intracellular indicators. Engineering optical management in a clinically related chimeric antigen receptor (CAR), we present that this restricted sign persistence will be exploited to extend CAR-T cell activation threefold utilizing pulsatile stimulation. Our outcomes are prone to apply extra typically to the signaling dynamics of different mobile networks.
Tumor rejection properties of gp100 209-specific T cells correlate with T cell receptor binding affinity in direction of the wild sort slightly than anchor-modified antigen
Though there are exceptions and outliers, T cell useful responses typically correlate with the affinity of a TCR for a peptide/MHC complicated. In a single just lately described outlier case, essentially the most promising medical candidate in a sequence of TCRs particular for the gp100209 melanoma antigen certain with the weakest resolution affinity and produced the least quantity of cytokine in vitro. Hypotheses for this outlier conduct included uncommon cytokine expression patterns arising from an atypical TCR binding geometry. Learning this occasion in additional element, we discovered right here that outlier conduct is attributable to not uncommon cytokine patterns or TCR binding, however the usage of a place 2 anchor-modified peptide variant in in vitro experiments as an alternative of the wild sort antigen that’s current in vivo.
Though the anchor-modified variant has been extensively utilized in fundamental and medical immunology as a surrogate for the wild sort peptide, prior work has proven that TCRs can clearly distinguish between the 2. We present that when this differential recognition is accounted for, the useful properties of gp100209-specific TCRs observe with their affinity in direction of the peptide/MHC complicated. Past demonstrating the correlates with T cell operate for a clinically related TCR, our outcomes present necessary concerns for choice of TCRs for immunotherapy and the usage of modified peptides in immunology.
 EBAG9 Antibody |
|||
| ABD6703 | Lifescience Market | 100 ug | EUR 438 |
 EBAG9 antibody |
|||
| 70R-16981 | Fitzgerald | 50 ul | EUR 435 |
|
Description: Rabbit polyclonal EBAG9 antibody |
|||
EBAG9 Antibody |
|||
| DF6703 | Affbiotech | 200ul | EUR 304 |
|
Description: EBAG9 Antibody detects endogenous levels of total EBAG9. |
|||
EBAG9 Antibody |
|||
| 1-CSB-PA007355GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against EBAG9. Recognizes EBAG9 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
|||
 EBAG9 siRNA |
|||
| 20-abx914879 | Abbexa |
|
|
EBAG9 siRNA |
|||
| 20-abx914880 | Abbexa |
|
|
EBAG9 siRNA |
|||
| 20-abx901624 | Abbexa |
|
|
EBAG9 antibody |
|||
| 38323-100ul | SAB | 100ul | EUR 252 |
) EBAG9 protein (His tag) |
|||
| 80R-1093 | Fitzgerald | 100 ug | EUR 224 |
|
Description: Purified recombinant Human EBAG9 protein |
|||
) RNU6-28 Recombinant Protein (Human) |
|||
| RP089073 | ABM | 100 ug | Ask for price |
 Recombinant HPV-28 E1 Protein |
|||
| VAng-Wyb3131-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Human papillomavirus type 28 Replication protein E1, recombinant protein. |
|||
 Recombinant HPV-28 L1 Protein |
|||
| VAng-Wyb3136-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Human papillomavirus type 28 Major capsid protein L1, recombinant protein. |
|||
) Anti-EBAG9 (4A10) |
|||
| YF-MA16699 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to EBAG9 |
|||
 EBAG9 Blocking Peptide |
|||
| 33R-2039 | Fitzgerald | 100 ug | EUR 180 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of EBAG9 antibody, catalog no. 70R-9916 |
|||
EBAG9 Blocking Peptide |
|||
| DF6703-BP | Affbiotech | 1mg | EUR 195 |
 EBAG9 cloning plasmid |
|||
| CSB-CL007355HU1-10ug | Cusabio | 10ug | EUR 233 |
|
Description: A cloning plasmid for the EBAG9 gene. |
|||
EBAG9 cloning plasmid |
|||
| CSB-CL007355HU2-10ug | Cusabio | 10ug | EUR 233 |
|
Description: A cloning plasmid for the EBAG9 gene. |
|||
 pCMV-SPORT6-EBAG9 |
|||
| PVT13493 | Lifescience Market | 2 ug | EUR 391 |
 EBAG9 Rabbit pAb |
|||
| A1935-100ul | Abclonal | 100 ul | EUR 308 |
EBAG9 Rabbit pAb |
|||
| A1935-200ul | Abclonal | 200 ul | EUR 459 |
EBAG9 Rabbit pAb |
|||
| A1935-20ul | Abclonal | 20 ul | EUR 183 |
EBAG9 Rabbit pAb |
|||
| A1935-50ul | Abclonal | 50 ul | EUR 223 |
EBAG9 Rabbit pAb |
|||
| A8385-100ul | Abclonal | 100 ul | EUR 308 |
EBAG9 Rabbit pAb |
|||
| A8385-200ul | Abclonal | 200 ul | EUR 459 |
EBAG9 Rabbit pAb |
|||
| A8385-20ul | Abclonal | 20 ul | Ask for price |
EBAG9 Rabbit pAb |
|||
| A8385-50ul | Abclonal | 50 ul | Ask for price |
 Human EBAG9 Antibody |
|||
| 32605-05111 | AssayPro | 150 ug | EUR 261 |
 Anti-EBAG9 antibody |
|||
| STJ23462 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor, which binds to the estrogen-responsive element found in the 5'-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Alternate splicing results in multiple transcript variants. A pseudogene of this gene has been defined on chromosome 10. |
|||
Anti-EBAG9 antibody |
|||
| STJ110683 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor, which binds to the estrogen-responsive element found in the 5'-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Alternate splicing results in multiple transcript variants. A pseudogene of this gene has been defined on chromosome 10. |
|||
 Anti-EBAG9 Antibody |
|||
| PB9553 | BosterBio | 100ug/vial | EUR 334 |
 EBAG9 Conjugated Antibody |
|||
| C38323 | SAB | 100ul | EUR 397 |
 Recombinant Human Vacuolar Protein Sorting 28 |
|||
| 7-06871 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Vacuolar Protein Sorting 28 |
|||
| 7-06872 | CHI Scientific | 50µg | Ask for price |
Recombinant Human Vacuolar Protein Sorting 28 |
|||
| 7-06873 | CHI Scientific | 1mg | Ask for price |
 Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-100ug |
|||
| QP5959-ec-100ug | EnQuireBio | 100ug | EUR 408 |
 Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-10ug |
|||
| QP5959-ec-10ug | EnQuireBio | 10ug | EUR 200 |
 Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-1mg |
|||
| QP5959-ec-1mg | EnQuireBio | 1mg | EUR 1632 |
 Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-200ug |
|||
| QP5959-ec-200ug | EnQuireBio | 200ug | EUR 634 |
 Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-500ug |
|||
| QP5959-ec-500ug | EnQuireBio | 500ug | EUR 1060 |
 Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-50ug |
|||
| QP5959-ec-50ug | EnQuireBio | 50ug | EUR 263 |
 IL-28, human recombinant |
|||
| 4978-1000 | Biovision | EUR 5204 | |
IL-28, human recombinant |
|||
| 4978-20 | Biovision | EUR 294 | |
) Recombinant Keratin 28 (KRT28) |
|||
| 4-RPS214Mu01 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Keratin 28 expressed in: E.coli |
|||
) Matrix Metalloproteinase-28 (Recombinant) |
|||
| 20-abx073425 | Abbexa |
|
|
 Rat EBAG9 shRNA Plasmid |
|||
| 20-abx989010 | Abbexa |
|
|
 Mouse EBAG9 shRNA Plasmid |
|||
| 20-abx974569 | Abbexa |
|
|
 Human EBAG9 shRNA Plasmid |
|||
| 20-abx956064 | Abbexa |
|
|
) Polyclonal EBAG9 Antibody (Center) |
|||
| APR04492G | Leading Biology | 0.1ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EBAG9 (Center). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal EBAG9 Antibody (Center) |
|||
| APR06938G | Leading Biology | 0.1ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EBAG9 (Center). This antibody is tested and proven to work in the following applications: |
|||
 Anti-EBAG9 / RCAS1 antibody |
|||
| STJ70947 | St John's Laboratory | 100 µg | EUR 359 |
) Recombinant Rat ALCAM Protein (aa 28-583) |
|||
| VAng-2940Lsx-100g | Creative Biolabs | 100 µg | EUR 7254 |
|
Description: Recombinant Rat ALCAM is expressed in cell free expression systems. (Uniprot ID: O35112) |
|||
Recombinant Rat ALCAM Protein (aa 28-583) |
|||
| VAng-2940Lsx-50g | Creative Biolabs | 50 µg | EUR 4765 |
|
Description: Recombinant Rat ALCAM is expressed in cell free expression systems. (Uniprot ID: O35112) |
|||
) Recombinant Rabbit ALCAM Protein (aa 28-527) |
|||
| VAng-2947Lsx-100g | Creative Biolabs | 100 µg | EUR 1150 |
|
Description: Recombinant Rabbit ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Rabbit ALCAM Protein (aa 28-527) |
|||
| VAng-2947Lsx-1mg | Creative Biolabs | 1 mg | EUR 3913 |
|
Description: Recombinant Rabbit ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Rabbit ALCAM Protein (aa 28-527) |
|||
| VAng-2947Lsx-500g | Creative Biolabs | 500 µg | EUR 2663 |
|
Description: Recombinant Rabbit ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
) Recombinant Human ALCAM Protein (aa 28-516) |
|||
| VAng-2950Lsx-1mg | Creative Biolabs | 1 mg | EUR 3390 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Human ALCAM Protein (aa 28-516) |
|||
| VAng-2950Lsx-200g | Creative Biolabs | 200 µg | EUR 1370 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Human ALCAM Protein (aa 28-516) |
|||
| VAng-2950Lsx-500g | Creative Biolabs | 500 µg | EUR 2223 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
) Recombinant Bovine ALCAM Protein (aa 28-527) |
|||
| VAng-2957Lsx-1mg | Creative Biolabs | 1 mg | EUR 5852 |
|
Description: Recombinant Bovine ALCAM is expressed in E. coli. (Uniprot ID: Q9BH13) |
|||
Recombinant Bovine ALCAM Protein (aa 28-527) |
|||
| VAng-2957Lsx-500g | Creative Biolabs | 500 µg | EUR 3583 |
|
Description: Recombinant Bovine ALCAM is expressed in E. coli. (Uniprot ID: Q9BH13) |
|||
) Recombinant Mouse ALCAM Protein (aa 28-527) |
|||
| VAng-2959Lsx-500g | Creative Biolabs | 500 µg | EUR 6415 |
|
Description: Recombinant Mouse ALCAM is expressed in HEK 293 Cells. (Uniprot ID: Q61490) |
|||
Recombinant Mouse ALCAM Protein (aa 28-527) |
|||
| VAng-2959Lsx-50g | Creative Biolabs | 50 µg | EUR 1246 |
|
Description: Recombinant Mouse ALCAM is expressed in HEK 293 Cells. (Uniprot ID: Q61490) |
|||
 PRSS28 Protease Serine 28 Mouse Recombinant Protein |
|||
| PROTQ924N9 | BosterBio | Regular: 5ug | EUR 317 |
|
Description: PRSS28 Mouse Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 256 amino acids (27-274a.a.) and having a molecular mass of 28.7kDa (Molecular size on SDS-PAGE will appear at approximately 28-40kDa)._x000D_PRSS28 is expressed with an 8 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques. |
|||
 MMP28 Matrix Metalloproteinase-28 Human Recombinant Protein |
|||
| PROTQ9H239 | BosterBio | Regular: 20ug | EUR 317 |
|
Description: MMP28 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 421 amino acids (123-520a.a) and having a molecular mass of 47.3kDa. MMP28 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
) Recombinant CD155 Protein (Asp 28-Asn 343) |
|||
| VAng-1181Lsx-100g | Creative Biolabs | 100 µg | EUR 1013 |
|
Description: Rhesus macaque CD155 is expressed in HEK 293 cells. (Uniprot ID: Q0MSE6-1) |
|||
Recombinant CD155 Protein (Asp 28-Asn 343) |
|||
| VAng-1181Lsx-1mg | Creative Biolabs | 1 mg | EUR 6402 |
|
Description: Rhesus macaque CD155 is expressed in HEK 293 cells. (Uniprot ID: Q0MSE6-1) |
|||
) Recombinant Erythropoietin Protein (Ala 28-Arg 193) |
|||
| VAng-1516Lsx-20g | Creative Biolabs | 20 µg | EUR 594 |
|
Description: Human Erythropoietin (EPO) is expressed in HEK 293 cells. (Uniprot ID: AAH93628.1) |
|||
Recombinant Erythropoietin Protein (Ala 28-Arg 193) |
|||
| VAng-1516Lsx-50g | Creative Biolabs | 50 µg | EUR 1013 |
|
Description: Human Erythropoietin (EPO) is expressed in HEK 293 cells. (Uniprot ID: AAH93628.1) |
|||
) Recombinant Salmonella leuL Protein (aa 1-28) |
|||
| VAng-Wyb0496-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2577 |
|
Description: Salmonella typhi Leu operon leader peptide, recombinant protein. |
|||
Recombinant Salmonella leuL Protein (aa 1-28) |
|||
| VAng-Wyb0496-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1747 |
|
Description: Salmonella typhi Leu operon leader peptide, recombinant protein. |
|||
Recombinant Salmonella leuL Protein (aa 1-28) |
|||
| VAng-Wyb0496-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1197 |
|
Description: Salmonella typhi Leu operon leader peptide, recombinant protein. |
|||
 VPS28 Vacuolar Protein Sorting 28 Human Recombinant Protein |
|||
| PROTQ9UK41 | BosterBio | Regular: 50ug | EUR 317 |
|
Description: VPS28 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 221 amino acids (1-221 a.a.) and having a molecular mass of 25.4kDa.;The VPS28 is purified by proprietary chromatographic techniques. |
|||
 (pPB-C-His)) EBAG9 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV174238 | ABM | 500 ng | EUR 603 |
 (pPB-N-His)) EBAG9 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV174239 | ABM | 500 ng | EUR 603 |
 (pPM-C-HA)) EBAG9 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV174240 | ABM | 500 ng | EUR 603 |
 (pPM-C-His)) EBAG9 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV174241 | ABM | 500 ng | EUR 603 |
 (pPB-C-His)) EBAG9 Protein Vector (Rat) (pPB-C-His) |
|||
| PV265294 | ABM | 500 ng | EUR 603 |
 (pPB-N-His)) EBAG9 Protein Vector (Rat) (pPB-N-His) |
|||
| PV265295 | ABM | 500 ng | EUR 603 |
 (pPM-C-HA)) EBAG9 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV265296 | ABM | 500 ng | EUR 603 |
 (pPM-C-His)) EBAG9 Protein Vector (Rat) (pPM-C-His) |
|||
| PV265297 | ABM | 500 ng | EUR 603 |
 (pPB-C-His)) EBAG9 Protein Vector (Human) (pPB-C-His) |
|||
| PV013461 | ABM | 500 ng | EUR 329 |
 (pPB-N-His)) EBAG9 Protein Vector (Human) (pPB-N-His) |
|||
| PV013462 | ABM | 500 ng | EUR 329 |
 (pPM-C-HA)) EBAG9 Protein Vector (Human) (pPM-C-HA) |
|||
| PV013463 | ABM | 500 ng | EUR 329 |
 (pPM-C-His)) EBAG9 Protein Vector (Human) (pPM-C-His) |
|||
| PV013464 | ABM | 500 ng | EUR 329 |
EBAG9 Protein Vector (Human) (pPB-C-His) |
|||
| PV013465 | ABM | 500 ng | EUR 329 |
EBAG9 Protein Vector (Human) (pPB-N-His) |
|||
| PV013466 | ABM | 500 ng | EUR 329 |
EBAG9 Protein Vector (Human) (pPM-C-HA) |
|||
| PV013467 | ABM | 500 ng | EUR 329 |
EBAG9 Protein Vector (Human) (pPM-C-His) |
|||
| PV013468 | ABM | 500 ng | EUR 329 |
) Recombinant Streptococcus Faecium Protein P54 Protein (aa 28-516) |
|||
| VAng-Cr7609-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5302 |
|
Description: Streptococcus Faecium Protein P54, recombinant protein. |
|||
Recombinant Streptococcus Faecium Protein P54 Protein (aa 28-516) |
|||
| VAng-Cr7609-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3748 |
|
Description: Streptococcus Faecium Protein P54, recombinant protein. |
|||
Recombinant Streptococcus Faecium Protein P54 Protein (aa 28-516) |
|||
| VAng-Cr7609-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2553 |
|
Description: Streptococcus Faecium Protein P54, recombinant protein. |
|||
 (pORF)) Ebag9 ORF Vector (Rat) (pORF) |
|||
| ORF066324 | ABM | 1.0 ug DNA | EUR 506 |
 (pORF)) EBAG9 ORF Vector (Human) (pORF) |
|||
| ORF003366 | ABM | 1.0 ug DNA | EUR 95 |
EBAG9 ORF Vector (Human) (pORF) |
|||
| ORF003367 | ABM | 1.0 ug DNA | EUR 95 |
 (pORF)) Ebag9 ORF Vector (Mouse) (pORF) |
|||
| ORF043560 | ABM | 1.0 ug DNA | EUR 506 |
) Human EBAG9 Antibody (Biotin Conjugate) |
|||
| 32605-05121 | AssayPro | 150 ug | EUR 369 |
 (OKCA02302)) EBAG9 ELISA Kit (Human) (OKCA02302) |
|||
| OKCA02302 | Aviva Systems Biology | 96 Wells | EUR 930 |
|
Description: Description of target: May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: 0.195 U/mL. |
|||
 (OKEH05822)) EBAG9 ELISA Kit (Human) (OKEH05822) |
|||
| OKEH05822 | Aviva Systems Biology | 96 Wells | EUR 662 |
|
Description: Description of target: May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.39U/L |
|||
) Recombinant Trypanosoma Brucei PARPB Protein (aa 28-123) |
|||
| VAng-Wyb8133-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2814 |
|
Description: Trypanosoma Brucei brucei Procyclic form-specific polypeptide B-alpha protein, recombinant protein. |
|||
Recombinant Trypanosoma Brucei PARPB Protein (aa 28-123) |
|||
| VAng-Wyb8133-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2016 |
|
Description: Trypanosoma Brucei brucei Procyclic form-specific polypeptide B-alpha protein, recombinant protein. |
|||
Recombinant Trypanosoma Brucei PARPB Protein (aa 28-123) |
|||
| VAng-Wyb8133-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1398 |
|
Description: Trypanosoma Brucei brucei Procyclic form-specific polypeptide B-alpha protein, recombinant protein. |
|||
) Recombinant Trypanosoma Brucei PROA Protein (aa 28-93) |
|||
| VAng-Wyb8152-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2649 |
|
Description: Trypanosoma Brucei brucei Procyclic form-specific polypeptide protein, recombinant protein. |
|||
Recombinant Trypanosoma Brucei PROA Protein (aa 28-93) |
|||
| VAng-Wyb8152-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1879 |
|
Description: Trypanosoma Brucei brucei Procyclic form-specific polypeptide protein, recombinant protein. |
|||
Recombinant Trypanosoma Brucei PROA Protein (aa 28-93) |
|||
| VAng-Wyb8152-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1301 |
|
Description: Trypanosoma Brucei brucei Procyclic form-specific polypeptide protein, recombinant protein. |
|||
) Recombinant Mycobacterium Tuberculosis Rv2011c Protein (aa 28-143) |
|||
| VAng-Yyj0692-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1454 |
|
Description: Mycobacterium Tuberculosis Uncharacterized protein Rv2011c/MT2066 (Rv2011c, MT2066), recombinant protein. |
|||
) Recombinant Mycobacterium Tuberculosis Rv3786c Protein (aa 28-407) |
|||
| VAng-Yyj0754-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2238 |
|
Description: Mycobacterium Tuberculosis Uncharacterized protein Rv3786c/MT3894 (Rv3786c, MT3894), recombinant protein. |
|||
) Recombinant Mycobacterium Leprae lprB Protein (aa 28-188) |
|||
| VAng-Yyj1725-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1594 |
|
Description: Mycobacterium Leprae Putative lipoprotein lprB (lprB), recombinant protein. |
|||
) Recombinant Mycobacterium Smegmatis MSMEG_5130 Protein (aa 28-627) |
|||
| VAng-Yyj4733-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Probable monoacyl phosphatidylinositol tetramannoside-binding protein LpqW (MSMEG_5130), recombinant protein. |
|||
) Recombinant Mycobacterium Smegmatis mspA Protein (aa 28-211) |
|||
| VAng-Yyj4987-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3377 |
|
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Porin MspA (mspA), recombinant protein. |
|||
Recombinant Mycobacterium Smegmatis mspA Protein (aa 28-211) |
|||
| VAng-Yyj4987-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2415 |
|
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Porin MspA (mspA), recombinant protein. |
|||
Recombinant Mycobacterium Smegmatis mspA Protein (aa 28-211) |
|||
| VAng-Yyj4987-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1645 |
|
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Porin MspA (mspA), recombinant protein. |
|||
 Protein) Recombinant HPV-28 E2 (aa 1-376) Protein |
|||
| VAng-Wyb3132-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4587 |
|
Description: Human papillomavirus type 28 Regulatory protein E2, recombinant protein. |
|||
Recombinant HPV-28 E2 (aa 1-376) Protein |
|||
| VAng-Wyb3132-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3239 |
|
Description: Human papillomavirus type 28 Regulatory protein E2, recombinant protein. |
|||
Recombinant HPV-28 E2 (aa 1-376) Protein |
|||
| VAng-Wyb3132-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2209 |
|
Description: Human papillomavirus type 28 Regulatory protein E2, recombinant protein. |
|||
 Protein) Recombinant HPV-28 E4 (aa 1-99) Protein |
|||
| VAng-Wyb3133-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2840 |
|
Description: Human papillomavirus type 28 Probable protein E4, recombinant protein. |
|||
Recombinant HPV-28 E4 (aa 1-99) Protein |
|||
| VAng-Wyb3133-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2030 |
|
Description: Human papillomavirus type 28 Probable protein E4, recombinant protein. |
|||
Recombinant HPV-28 E4 (aa 1-99) Protein |
|||
| VAng-Wyb3133-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1398 |
|
Description: Human papillomavirus type 28 Probable protein E4, recombinant protein. |
|||
 Protein) Recombinant HPV-28 E6 (aa 1-146) Protein |
|||
| VAng-Wyb3134-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3129 |
|
Description: Human papillomavirus type 28 protein E6, recombinant protein. |
|||
Recombinant HPV-28 E6 (aa 1-146) Protein |
|||
| VAng-Wyb3134-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2236 |
|
Description: Human papillomavirus type 28 protein E6, recombinant protein. |
|||
Recombinant HPV-28 E6 (aa 1-146) Protein |
|||
| VAng-Wyb3134-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1549 |
|
Description: Human papillomavirus type 28 protein E6, recombinant protein. |
|||
 Protein) Recombinant HPV-28 E7 (aa 1-87) Protein |
|||
| VAng-Wyb3135-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2785 |
|
Description: Human papillomavirus type 28 protein E7, recombinant protein. |
|||
Recombinant HPV-28 E7 (aa 1-87) Protein |
|||
| VAng-Wyb3135-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1975 |
|
Description: Human papillomavirus type 28 protein E7, recombinant protein. |
|||
Recombinant HPV-28 E7 (aa 1-87) Protein |
|||
| VAng-Wyb3135-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1370 |
|
Description: Human papillomavirus type 28 protein E7, recombinant protein. |
|||
 Protein) Recombinant HPV-28 L2 (aa 1-473) Protein |
|||
| VAng-Wyb3137-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5205 |
|
Description: Human papillomavirus type 28 Minor capsid protein L2, recombinant protein. |
|||
Recombinant HPV-28 L2 (aa 1-473) Protein |
|||
| VAng-Wyb3137-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3679 |
|
Description: Human papillomavirus type 28 Minor capsid protein L2, recombinant protein. |
|||
Recombinant HPV-28 L2 (aa 1-473) Protein |
|||
| VAng-Wyb3137-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2511 |
|
Description: Human papillomavirus type 28 Minor capsid protein L2, recombinant protein. |
|||
) Recombinant Schizosaccharomyces Pombe tim50 Protein (aa 28-452) |
|||
| VAng-Yyj5949-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Schizosaccharomyces Pombe (strain 972 / ATCC 24843) (Fission yeast) Mitochondrial import inner membrane translocase subunit tim50 (tim50), recombinant protein. |
|||
) Recombinant Mycobacterium Bovis Mb2034c Protein (aa 28-143) |
|||
| VAng-Yyj2888-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2940 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb2034c (Mb2034c), recombinant protein. |
|||
Recombinant Mycobacterium Bovis Mb2034c Protein (aa 28-143) |
|||
| VAng-Yyj2888-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2109 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb2034c (Mb2034c), recombinant protein. |
|||
Recombinant Mycobacterium Bovis Mb2034c Protein (aa 28-143) |
|||
| VAng-Yyj2888-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1454 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb2034c (Mb2034c), recombinant protein. |
|||
) Recombinant Mycobacterium Bovis Mb1845 Protein (aa 28-221) |
|||
| VAng-Yyj3040-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3432 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb1845 (Mb1845), recombinant protein. |
|||
Recombinant Mycobacterium Bovis Mb1845 Protein (aa 28-221) |
|||
| VAng-Yyj3040-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2456 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb1845 (Mb1845), recombinant protein. |
|||
Recombinant Mycobacterium Bovis Mb1845 Protein (aa 28-221) |
|||
| VAng-Yyj3040-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1673 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb1845 (Mb1845), recombinant protein. |
|||
) Recombinant Mycobacterium Bovis Mb3815c Protein (aa 28-407) |
|||
| VAng-Yyj3128-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4614 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb3815c (Mb3815c), recombinant protein. |
|||
Recombinant Mycobacterium Bovis Mb3815c Protein (aa 28-407) |
|||
| VAng-Yyj3128-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3268 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb3815c (Mb3815c), recombinant protein. |
|||
Recombinant Mycobacterium Bovis Mb3815c Protein (aa 28-407) |
|||
| VAng-Yyj3128-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2236 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb3815c (Mb3815c), recombinant protein. |
|||
) Recombinant Escherichia coli lptA Protein (aa 28-185) |
|||
| VAng-Lsx02468-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3294 |
|
Description: Escherichia coli Lipopolysaccharide export system protein LptA, recombinant protein. |
|||
Recombinant Escherichia coli lptA Protein (aa 28-185) |
|||
| VAng-Lsx02468-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2113 |
|
Description: Escherichia coli Lipopolysaccharide export system protein LptA, recombinant protein. |
|||
Recombinant Escherichia coli lptA Protein (aa 28-185) |
|||
| VAng-Lsx02468-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 573 |
|
Description: Escherichia coli Lipopolysaccharide export system protein LptA, recombinant protein. |
|||
) Recombinant Haemophilus Influenzae hifB Protein (aa 28-241) |
|||
| VAng-Lsx03394-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3569 |
|
Description: Haemophilus Influenzae Chaperone protein hifB, recombinant protein. |
|||
Recombinant Haemophilus Influenzae hifB Protein (aa 28-241) |
|||
| VAng-Lsx03394-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2553 |
|
Description: Haemophilus Influenzae Chaperone protein hifB, recombinant protein. |
|||
Recombinant Haemophilus Influenzae hifB Protein (aa 28-241) |
|||
| VAng-Lsx03394-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1728 |
|
Description: Haemophilus Influenzae Chaperone protein hifB, recombinant protein. |
|||
) Recombinant Shigella Flexneri fruL Protein (aa 1-28) |
|||
| VAng-Lsx07766-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2401 |
|
Description: Shigella Flexneri Putative fruR/shl operon leader peptide, recombinant protein. |
|||
Recombinant Shigella Flexneri fruL Protein (aa 1-28) |
|||
| VAng-Lsx07766-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1714 |
|
Description: Shigella Flexneri Putative fruR/shl operon leader peptide, recombinant protein. |
|||
Recombinant Shigella Flexneri fruL Protein (aa 1-28) |
|||
| VAng-Lsx07766-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1191 |
|
Description: Shigella Flexneri Putative fruR/shl operon leader peptide, recombinant protein. |
|||
) Recombinant Shigella Flexneri hybA Protein (aa 28-328) |
|||
| VAng-Lsx07858-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4119 |
|
Description: Shigella Flexneri Hydrogenase-2 operon protein hybA, recombinant protein. |
|||
Recombinant Shigella Flexneri hybA Protein (aa 28-328) |
|||
| VAng-Lsx07858-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2909 |
|
Description: Shigella Flexneri Hydrogenase-2 operon protein hybA, recombinant protein. |
|||
Recombinant Shigella Flexneri hybA Protein (aa 28-328) |
|||
| VAng-Lsx07858-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1989 |
|
Description: Shigella Flexneri Hydrogenase-2 operon protein hybA, recombinant protein. |
|||
) Recombinant Shigella Flexneri leuL Protein (aa 1-28) |
|||
| VAng-Lsx07886-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2401 |
|
Description: Shigella Flexneri Leu operon leader peptide, recombinant protein. |
|||
Recombinant Shigella Flexneri leuL Protein (aa 1-28) |
|||
| VAng-Lsx07886-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1714 |
|
Description: Shigella Flexneri Leu operon leader peptide, recombinant protein. |
|||
Recombinant Shigella Flexneri leuL Protein (aa 1-28) |
|||
| VAng-Lsx07886-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1191 |
|
Description: Shigella Flexneri Leu operon leader peptide, recombinant protein. |
|||
) Recombinant Shigella Flexneri nrfC Protein (aa 28-223) |
|||
| VAng-Lsx07990-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3445 |
|
Description: Shigella Flexneri Protein nrfC, recombinant protein. |
|||
Recombinant Shigella Flexneri nrfC Protein (aa 28-223) |
|||
| VAng-Lsx07990-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2470 |
|
Description: Shigella Flexneri Protein nrfC, recombinant protein. |
|||
Recombinant Shigella Flexneri nrfC Protein (aa 28-223) |
|||
| VAng-Lsx07990-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1673 |
|
Description: Shigella Flexneri Protein nrfC, recombinant protein. |
|||
) Recombinant Shigella Flexneri pagP Protein (aa 28-186) |
|||
| VAng-Lsx08010-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3213 |
|
Description: Shigella Flexneri Lipid A palmitoyltransferase PagP, recombinant protein. |
|||
Recombinant Shigella Flexneri pagP Protein (aa 28-186) |
|||
| VAng-Lsx08010-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2305 |
|
Description: Shigella Flexneri Lipid A palmitoyltransferase PagP, recombinant protein. |
|||
Recombinant Shigella Flexneri pagP Protein (aa 28-186) |
|||
| VAng-Lsx08010-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1576 |
|
Description: Shigella Flexneri Lipid A palmitoyltransferase PagP, recombinant protein. |
|||
) Recombinant Shigella Flexneri yddW Protein (aa 28-439) |
|||
| VAng-Lsx08346-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4820 |
|
Description: Shigella Flexneri UPF0748 lipoprotein yddW, recombinant protein. |
|||
Recombinant Shigella Flexneri yddW Protein (aa 28-439) |
|||
| VAng-Lsx08346-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3404 |
|
Description: Shigella Flexneri UPF0748 lipoprotein yddW, recombinant protein. |
|||
Recombinant Shigella Flexneri yddW Protein (aa 28-439) |
|||
| VAng-Lsx08346-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2319 |
|
Description: Shigella Flexneri UPF0748 lipoprotein yddW, recombinant protein. |
|||
Proliferating cell nuclear antigen straight interacts with androgen receptor and enhances androgen receptor‑mediated signaling
Androgen receptor (AR) and/or its constitutively lively splicing variants (AR‑Vs), reminiscent of AR‑V7 and ARv567es, is required for prostate most cancers cell development and survival, and most cancers development. Proliferating cell nuclear antigen (PCNA) is preferentially overexpressed in all cancers and executes its capabilities by way of interplay with quite a few accomplice proteins. The goal of the current research was to research the potential position of PCNA within the regulation of AR exercise.
An equivalent consensus sequence of the PCNA‑interacting protein‑field (PIP‑field) was recognized on the N‑terminus of human, mouse and rat AR proteins. It was discovered that PCNA complexes with the total‑size AR (AR‑FL) and AR‑V7, which will be attenuated by the small molecule PIP‑field inhibitor, T2AA. PCNA additionally complexes with ARv567es and recombinant AR protein. The PCNA inhibitors, PCNA‑I1S and T2AA, inhibited AR transcriptional exercise and the expression of AR goal genes in LNCaP‑AI and 22Rv1 cells, however not in AR‑detrimental PC‑three cells. The knockdown of PCNA expression lowered dihydrotestosterone‑stimulated AR transcriptional exercise and abolished the inhibitory impact of PCNA‑I1S on AR exercise. The PCNA inhibitor, PCNA‑I1, exerted additive development inhibitory results with androgen deprivation and enzalutamide in cells expressing AR‑FL or AR‑FL/AR‑V7, however not in AR‑detrimental PC‑three cells.
Lastly, R9‑AR‑PIP, a small peptide mimicking AR PIP‑field, was discovered to bind to GFP‑PCNA at Okd of two.73 µM and inhibit the expression of AR goal genes, AR transcriptional exercise and the expansion of AR‑expressing cells. On the entire, these information strongly recommend that AR is a PCNA accomplice protein and interacts with PCNA through the PIP‑field and that focusing on the PCNA‑AR interplay might characterize an progressive and selective therapeutic technique towards prostate most cancers, notably castration‑resistant prostate cancers overexpressing constitutively lively AR‑Vs.
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells successfully remove human glioblastoma
Targets: The rising success of Chimeric Antigen Receptor (CAR) T cell remedy in haematological malignancies is reinvigorating its software in lots of different most cancers varieties and with renewed concentrate on its software to strong tumors. We current a novel CAR towards glioblastoma, an aggressive, malignant glioma, with a dismal survival charge for which therapy choices have remained unchanged for over a decade.
Strategies: We use the human Retained Show (ReD) antibody platform (Myrio Therapeutics) to establish a novel single-chain variable fragment (scFv) that recognises epidermal development issue receptor mutant variant III (EGFRvIII), a typical and tumor-specific mutation present in glioblastoma. We use each in vitro useful assays and an in vivo orthotopic xenograft mannequin of glioblastoma to look at the operate of our novel CAR, known as GCT02, focused utilizing murine CAR T cells.
Outcomes: Our EGFRvIII-specific scFv was discovered to be of a lot increased affinity than reported comparators reverse-engineered from monoclonal antibodies. Regardless of the upper affinity, GCT02 CAR T cells kill equivalently however secrete decrease quantities of cytokine. As well as, GCT02-CAR T cells additionally mediate fast and full tumor elimination in vivo.
Conclusion: We current a novel EGFRvIII-specific CAR, with efficient antitumor capabilities each in in vitro and in a xenograft mannequin of human glioblastoma.
 (UbC) (pLenti-GIII-UbC)) OR52M2P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739227 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OR52N3P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739233 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OR52P1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739239 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OR52P2P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739245 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OR52Q1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739251 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OR52S1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739257 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OR52T1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739263 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OR52U1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739269 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OR52V1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739275 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OR52X1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739281 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OR52Y1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739287 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OR55B1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739293 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OR56A7P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739299 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OR56B2P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739305 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OR56B3P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739311 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) ORAOV1P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739317 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OSTCP2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739335 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OSTCP3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739341 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OSTCP4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739347 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OSTCP5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739353 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OSTCP6 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739359 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OSTCP7 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739365 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OSTCP8 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739371 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OTSC1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739389 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OTSC2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739395 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OTSC3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739401 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OTSC4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739407 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OTSC5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739413 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OTSC6 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739419 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OTSC7 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739425 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OTSC8 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739431 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OTSC9 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739437 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OTSC10 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739443 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) OTX2P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739449 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739461 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) P2RY10P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739467 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) P2RY10P2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739473 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PA2G4P2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739485 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PA2G4P3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739491 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PA2G4P5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739497 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PA2G4P6 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739503 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PABPC1P5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739509 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PABPC1P6 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739515 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PABPC1P7 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739521 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PABPC1P8 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739527 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PABPC1P10 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739533 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PABPC1P11 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739539 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PABPC1P12 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739545 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PABX Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739557 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PABY Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739563 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PAFAH1B1P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739569 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PAFAH1B1P2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739575 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PAICSP1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739581 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PAICSP6 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739587 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PAIP1P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739593 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PARK3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739599 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PARK10 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739605 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PARK11 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739611 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PARK12 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739617 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PARK16 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739623 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PARP1P2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739629 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PARP4P3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739641 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PBCRA1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739647 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PBG1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739653 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCAP Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739659 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCBP2P2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739665 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCBP2P3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739671 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCDH8P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739689 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCDHA14 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739719 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCDHACT Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739731 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCDHGB9P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739749 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCDHGCT Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739755 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCMTD1P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739761 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCMTD1P2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739767 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCMTD1P3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739773 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCNPP1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739785 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCNPP2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739791 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCNPP3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739797 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCNPP4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739803 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCNPP5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739809 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PCOS1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739815 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PDB1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739827 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PDB2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739833 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PDB4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739839 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PDB5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739845 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PDB6 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739851 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PDCL3P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739857 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PDCL3P2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739863 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PDLIM1P Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739869 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) PDR Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV739875 | ABM | 1.0 ug DNA | Ask for price |